Martínez-García, M., Velasco, G., Pineda, E., Gil-Gil, M. J., Alameda Quitllet, F., Capellades Font, J., . . . Sepúlveda-Sánchez, J. M. (2022). Safety and efficacy of crizotinib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib GEINO 1402 trial.
Citación estilo ChicagoMartínez-García, Maria, et al. Safety and Efficacy of Crizotinib in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. 2022.
Cita MLAMartínez-García, Maria, et al. Safety and Efficacy of Crizotinib in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. 2022.
Precaución: Estas citas no son 100% exactas.